ruthenium has been researched along with 1,1-diphenyl-2-picrylhydrazyl in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jayabalakrishnan, C; Sampath, K; Sathiyaraj, S | 1 |
| Ajibade, PA; Ejidike, IP | 1 |
| Harrypersad, S; MacNeil, GA; Mu, C; Panchmatia, R; Prosser, KE; Sinha, S; Thompson, JR; Walsby, CJ; Warren, JJ | 1 |
| Bian, L; Chakraborty, T; Chanda, P; Ghosh, T; Roy, S; Wang, Y | 1 |
| Chakraborty, T; Guo, Z; Jin, G; Mandal, A; Roy, A; Roy, S; Zhao, Z | 1 |
| Batista, AA; Cominetti, MR; Correa, RS; Graminha, AE; Honorato, J; Menezes, ACS | 1 |
6 other study(ies) available for ruthenium and 1,1-diphenyl-2-picrylhydrazyl
| Article | Year |
|---|---|
DNA binding, DNA cleavage, antioxidant and cytotoxicity studies on ruthenium(II) complexes of benzaldehyde 4-methyl-3-thiosemicarbazones.
Topics: Animals; Antineoplastic Agents; Antioxidants; Benzaldehydes; Biphenyl Compounds; Breast; Breast Neoplasms; Cattle; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; DNA; DNA Cleavage; Female; Free Radicals; Humans; Models, Molecular; Picrates; Ruthenium; Thiosemicarbazones | 2013 |
Ruthenium(III) Complexes of Heterocyclic Tridentate (ONN) Schiff Base: Synthesis, Characterization and its Biological Properties as an Antiradical and Antiproliferative Agent.
Topics: Antineoplastic Agents; Benzothiazoles; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Free Radical Scavengers; Heterocyclic Compounds; Humans; Ligands; Neoplasms; Picrates; Ruthenium; Schiff Bases; Sulfonic Acids | 2016 |
Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Antioxidants; Bacillus subtilis; Biphenyl Compounds; Cell Proliferation; Drug Screening Assays, Antitumor; Ferrous Compounds; HT29 Cells; Humans; Metallocenes; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organometallic Compounds; Oxidation-Reduction; Picrates; Ruthenium | 2018 |
Construing the Biochemical and Molecular Mechanism Underlying the
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Biphenyl Compounds; Catalase; Cell Proliferation; Colonic Neoplasms; Colorectal Neoplasms; Flavanones; Glutathione; HT29 Cells; Humans; Male; Picrates; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ruthenium; Superoxide Dismutase; TOR Serine-Threonine Kinases | 2019 |
Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events.
Topics: Aberrant Crypt Foci; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; Biphenyl Compounds; Cell Proliferation; Cell Survival; Colon; Colonic Neoplasms; DNA; Female; Free Radical Scavengers; HT29 Cells; Humans; Kidney; Male; Matrix Metalloproteinase 9; Mice, Inbred BALB C; NF-kappa B; Oxidation-Reduction; Phloretin; Picrates; Ruthenium; Spectroscopy, Fourier Transform Infrared; Sulfonic Acids; Toxicity Tests | 2020 |
A novel ruthenium(ii) gallic acid complex disrupts the actin cytoskeleton and inhibits migration, invasion and adhesion of triple negative breast tumor cells.
Topics: Actin Cytoskeleton; Animals; Antineoplastic Agents; Apoproteins; Biphenyl Compounds; Cell Adhesion; Cell Line; Cell Movement; Cell Survival; Coordination Complexes; Gallic Acid; Humans; Mice; Picrates; Pyridines; Ruthenium; Serum Albumin, Bovine; Transferrin; Triple Negative Breast Neoplasms | 2021 |